Peter Kenny

41 Followers

Physical-Organic, Computational and Medicinal Chemist with 20+ years Pharma experience in both Lead Identification and Lead Optimisation. My primary scientific focus is Molecular Design and I've linked a selection of recent publications that will give an idea of interests and expertise. Although currently retired (from AstraZeneca), I remain very interested in opportunities for sharing expertise and learning new skills. I can be very flexible in how I can work with science and research-based organisations.

molecular design lipophilicity fbdd ligand efficiency screening library drug discovery alkane/water octanol/water partition coefficient correlation inflation molecular recognition mmpa logp brazmedchem hydrogen bonding thermodynamics ripon college ligand efficiency metric matched molecular pair analysis chiwpc15 lle le lipe lipophilic efficiency units metrics voodoo thermodynamics property-based molecular design molecular de matched molecular pair molecular recog halogen workshop library design fragment screening screening raci drug-likeness correlaton inflation matched molecular pairs euroqsar

Aktivität
Info

Peter Kenny

Präsentationen

Hydrogen bonding and molecular design (EuroQSAR 2010)

Hydrogen bonding and molecular design (BrazMedChem 2010)

Tales of correlation inflation (2013 CADD GRC)

I'm a molecule designer... get me out of here!

Molecular design: One step back and two paths forward

An overview of drug discovery

From screening to molecular interactions: A short tour

Lipophilicity in the context of molecular design

Design of fragment screening libraries (Feb 2010 version)

Design of compound libraries for fragment screening (Feb 2012 version)

Design of fragment screening libraries (IQPC 2008)

Fragment screening library workshop (IQPC 2008)

A survey of halogens (2008 EuroCUP)

Molecular design: How to and how not to?

Some new directions for pharmaceutical molecular design

Perspective of pharmaceutical molecular design

Aspects of pharmaceutical molecular design

Data-analytic sins in property-based molecular design

UCT Oct 2014

IQSC Oct 2014

BrazMedChem2014

Aspects of pharmaceutical molecular design (Belgrade version)

Aspects of pharmaceutical molecular design (Fidelta version)

Ligand efficiency: nice concept shame about the metrics

Property-based molecular design: where next? (12-Jun-2015)

partition coefficients in drug discovery

Thermodynamics for medicinal chemistry design

Dokumente

PWK EuroQSAR

LE Metrics (EuroQSAR2016)